Overview
Patient-facing AI agents for defined healthcare outreach and coordination workflows.
What Hippocratic AI does
Hippocratic AI builds conversational agents for healthcare organizations. The agents support defined patient-facing workflows such as outreach, follow-up, scheduling and other interactions that require an understanding of healthcare context.
The platform is designed for deployment by health systems, payers and life-sciences organizations. Its safety-focused architecture and clinical evaluation process sit behind the agents, while the organization defines the intended use and how the work connects to its care teams.
This is enterprise healthcare software rather than an independent clinical practice. Its current product range includes different healthcare and administrative applications; the responsibilities and permitted actions depend on the specific deployment rather than a blanket claim that an AI agent can replace a clinician.
Company details
- Stage
- Series C
- Funding
- $126 million Series C; $404 million total (November 2025)
Founders & leadership
Investors & backers
Hippocratic AI announced a $126 million Series C led by Avenir Growth on November 3, 2025, bringing total funding to $404 million.
- Avenir Growth
- CapitalG
General Catalyst
Andreessen Horowitz
Kleiner Perkins- Premji Invest
- Universal Health Services
- Cincinnati Children’s Hospital Medical Center
- WellSpan Health
- John Doerr
- Rick Klausner
